Senior insider sale
Chief Technology Officer at OLEMA PHARMACEUTICALS, INC. — senior position signals high conviction
$144.7K
12.50K shares
What this filing means
HARMON CYRUS plans to sell 12.50K shares of OLEMA PHARMACEUTICALS, INC. valued at approximately $144.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/23/2026ACC: 0001959173-26-005343
DirectorOfficer· Chief Technology Officer
Since Nov 2020
12.50K
Shares to sell
$144.7K
Approx. market value
12.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Founders Shares
Compensation
3/20/2007
12.50KTotal acquired12.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/20/2007 | Founders Shares Compensation | 12.50K | — |
| Total | 12.50K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
12.50K
Market value
$144.7K
7/23/2026
Total
Units
12.50K
Value
$144.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/23/2026 | 12.50K | $144.7K | NASDAQ | Planned |
| Total | 12.50K | $144.7K | ||